Warning: The NCBI web site requires JavaScript to function. more...
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.
Giles JT, Fernandes V, Lima JA, Bathon JM.
Arthritis Res Ther. 2005;7(5):195-207. Epub 2005 Aug 24. Review.
Related citations
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A.
Arthritis Rheum. 2008 Mar;58(3):667-77.
Biologics and heart failure in rheumatoid arthritis: are we any wiser?
Danila MI, Patkar NM, Curtis JR, Saag KG, Teng GG.
Curr Opin Rheumatol. 2008 May;20(3):327-33. Review.
Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.
McInnes IB, Gracie JA.
Curr Rheumatol Rep. 2004 Oct;6(5):336-42. Review.
Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
Kaplan MJ.
Nat Clin Pract Rheumatol. 2005 Dec;1(2):74-5. No abstract available.
[Cytokines--causes, players or bystanders in heart failure].
Staudt A, Landsberger M, Staudt Y, Felix SB.
Herz. 2002 Nov;27(7):691-8. Review. German.
Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
Calamia KT.
Adv Exp Med Biol. 2003;528:545-9. Review. No abstract available.
Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis.
Spadaro A, Scrivo R, Riccieri V, Valesini G.
Joint Bone Spine. 2008 Jan;75(1):87-9. Epub 2007 Aug 28.
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
Weisman MH, Paulus HE, Burch FX, Kivitz AJ, Fierer J, Dunn M, Kerr DR, Tsuji W, Baumgartner SW.
Rheumatology (Oxford). 2007 Jul;46(7):1122-5. Epub 2007 Apr 29.
Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE.
Arthritis Rheum. 2008 Mar;58(3):637-40. No abstract available.
Cytokines and anti-cytokine biologicals in autoimmunity: present and future.
Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M.
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):299-313. Review.
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A.
JAMA. 2009 Feb 18;301(7):737-44.
Rheumatoid arthritis and accelerated atherogenesis.
Gonzalez-Juanatey C, Gonzalez-Gay MA.
Circulation. 2004 Jun 29;109(25):e328; author reply e328. No abstract available.
The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease.
Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J.
Semin Arthritis Rheum. 2005 Oct;35(2):132-3. No abstract available.
[Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P.
Rev Med Interne. 2008 Dec;29(12):971-4. Epub 2008 Jun 20. French. No abstract available.
[Rheumatoid arthritis: current status of therapy].
El Bahri DM, Meddeb N, Sellami S.
Tunis Med. 2007 Jan;85(1):1-8. Review. French.
Who might be predisposed to the development of serious side effects when treated with TNF-alpha antagonist?
Kotyla PJ, Kucharz EJ.
Clin Exp Rheumatol. 2006 Mar-Apr;24(2):211; author reply 211. No abstract available.
Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.
Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J.
Arthritis Rheum. 2006 Nov;54(11):3399-407.
Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL, Silman AJ.
J Rheumatol. 2006 May;33(5):831-3. No abstract available.
Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
Feldmann M, Brennan FM, Williams RO, Cope AP, Gibbons DL, Katsikis PD, Maini RN.
Prog Growth Factor Res. 1992;4(3):247-55. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on